NCT04931420

Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels

WITHDRAWNPHASE2INTERVENTIONAL

Trial Details

Start: 2022-05-19Est. Completion: 2026-05-01

Enrollment target: 0 participants

Other microbiome trials you might be interested in

Safety and Early Signs of Efficacy of IL12-L19L19.Phase 1Recruiting

Advanced Solid TumorMetastatic Solid Tumor

The purpose of this study is to describe the safety, tolerability and early signs of efficacy of the antibody-cytokine f…

Hamburg, GermanyEst. completion Dec 2026

View Trial →

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck CancerPhase 2Recruiting

Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Locally Recurrent Head and Neck Squamous Cell CarcinomaLocally Recurrent Hypopharyngeal Squamous Cell CarcinomaLocally Recurrent Laryngeal Squamous Cell Carcinoma

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.